DMAC
DiaMedica Therapeutics Inc.
$5.65
+3.48%
$304.4M
No data for this timeframe.
Vol
Market Cap$304.4M
Cap SizeSmall Cap
Inst. Holders45 funds
Inst. Value$29.1M
Inst. Activity6 buys / 5 sells
SEC Reports3
Recent Activity
Jun 11, 2026
SEC
Three mega-passive institutional investors (BlackRock, State Street, Morgan Stanley) collectively added $12.2M in DMAC d
INST-CLUSTER — Impact 3/10
Jun 1, 2026
Insider
Kuntz Richard was granted 40,412 shares
Director
Jun 1, 2026
Insider
Giuffre Randall Michael was granted 40,412 shares
Director
Jun 1, 2026
Insider
O'Connor Daniel J. was granted 40,412 shares
Director
May 6, 2026
SEC
DiaMedica reported Q1 2026 EPS of -$0.19, missing consensus of -$0.17 by 11.8%. Net loss widened to $10.0M from $7.7M a
8-K — Impact 6/10
Apr 1, 2026
SEC
Analysis based on filing metadata only — document content was unavailable
DEFA14A — Impact 3/10
Inst.
SEI INVESTMENTS CO — DOUBLED
111,320 shares ($753.6K)
Inst.
MORGAN STANLEY — NEAR_EXIT
105,420 shares ($713.7K)
Price Targets
Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$15.50 (Nov 2025)
Current $5.65
Low $11.00
Median $13.00
High $25.00
4 analysts
$11.00
$25.00
Analyst Ratings
2Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 14, 2025 | Cantor Fitzgerald | INITIATE | Overweight |
| Aug 15, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Jul 18, 2025 | Craig-Hallum | MAINTAIN | Buy → Buy |
| Jul 18, 2025 | Lake Street | MAINTAIN | Buy → Buy |
| Jul 18, 2025 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.20 ▼ -5.3% | $-0.21 — $-0.19 | -11% YoY | 4 |
| Next Q | $-0.21 ▼ -3.7% | $-0.24 — $-0.19 | -25% YoY | 4 |
| Current FY | $-0.83 ▼ -3.4% | $-0.90 — $-0.76 | -19% YoY | 4 |
| Next FY | $-0.88 ▼ -5.3% | $-1.05 — $-0.58 | -6% YoY | 5 |
Latest Reports
NEUTRAL
INST-CLUSTER
3/10
Three mega-passive institutional investors (BlackRock, State Street, Morgan Stanley) collectively added $12.2M in DMAC d
Jun 11, 2026
BEARISH
8-K
6/10
DiaMedica reported Q1 2026 EPS of -$0.19, missing consensus of -$0.17 by 11.8%. Net loss widened to $10.0M from $7.7M a
May 6, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $12.6M | ADD |
| STATE STREET CORP | $4.4M | ADD |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.3M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.4M | — |
| VANGUARD FIDUCIARY TRUST CO | $1.3M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Kuntz Richard | A | $0.00 |
| Jun 1, 2026 | Giuffre Randall | A | $0.00 |
| Jun 1, 2026 | O'Connor Daniel | A | $0.00 |
| Jun 1, 2026 | Semba Charles | A | $0.00 |
| Jun 1, 2026 | Kellen Scott | A | $0.00 |
45 institutional holders with $29.1M total value (4,328,272 shares) as of 2026-Q1. Top holders: BlackRock,, STATE, VANGUARD. Net buying activity: 6 institutions added/increased vs 5 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1,856,187 | $12.6M | 43.1% | ADD +40.8% |
| 2 | STATE STREET CORP | 644,211 | $4.4M | 15.0% | ADD +31.7% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 333,456 | $2.3M | 7.7% | — |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 203,459 | $1.4M | 4.7% | — |
| 5 | VANGUARD FIDUCIARY TRUST CO | 187,724 | $1.3M | 4.4% | — |
| 6 | CITADEL ADVISORS LLC | 145,724 | $986.6K | 3.4% | ADD +40.6% |
| 7 | SEI INVESTMENTS CO | 111,320 | $753.6K | 2.6% | DOUBLED +100.0% |
| 8 | MORGAN STANLEY | 105,420 | $713.7K | 2.4% | NEAR_EXIT -80.7% |
| 9 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 88,421 | $598.6K | 2.1% | DOUBLED +500.3% |
| 10 | Nuveen, LLC | 79,110 | $535.6K | 1.8% | TRIM -28.7% |
| 11 | ExodusPoint Capital Management, LP | 60,011 | $406.3K | 1.4% | — |
| 12 | GOLDMAN SACHS GROUP INC | 59,288 | $401.4K | 1.4% | — |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 52,523 | $355.6K | 1.2% | — |
| 14 | BANK OF AMERICA CORP /DE/ | 42,768 | $289.5K | 1.0% | ADD +62.5% |
| 15 | DEUTSCHE BANK AG\ | 28,354 | $192.0K | 0.7% | TRIM -25.6% |
| 16 | Invesco Ltd. | 24,799 | $167.9K | 0.6% | ADD +33.1% |
| 17 | ROYAL BANK OF CANADA | 23,343 | $157.0K | 0.5% | TRIM -50.3% |
| 18 | RHUMBLINE ADVISERS | 22,753 | $154.0K | 0.5% | — |
| 19 | Trexquant Investment LP | 22,261 | $150.7K | 0.5% | TRIM -28.1% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21,650 | $146.6K | 0.5% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| SEI INVESTMENTS CO | DOUBLED | 55,660 | 111,320 | +100.0% | $753.6K | 2026-Q1 |
| MORGAN STANLEY | NEAR_EXIT | 547,610 | 105,420 | -80.7% | $713.7K | 2026-Q1 |
| Nuveen, LLC | TRIM | 111,028 | 79,110 | -28.7% | $535.6K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 26,322 | 42,768 | +62.5% | $289.5K | 2026-Q1 |
| Invesco Ltd. | ADD | 18,628 | 24,799 | +33.1% | $167.9K | 2026-Q1 |
| Trexquant Investment LP | TRIM | 30,954 | 22,261 | -28.1% | $150.7K | 2026-Q1 |
| MetLife Investment Management, LLC | TRIM | 19,085 | 11,863 | -37.8% | $80.3K | 2026-Q1 |
| FMR LLC | DOUBLED | 1,804 | 10,463 | +480.0% | $70.8K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 101 | 8,189 | +8007.9% | $55.4K | 2026-Q1 |
| CWM, LLC | DOUBLED | 70 | 199 | +184.3% | $1.3K | 2026-Q1 |
| PNC FINANCIAL SERVICES GROUP, INC. | TRIM | 57 | 19 | -66.7% | $129.00 | 2026-Q1 |
| STATE STREET CORP | ADD | 476,583 | 627,771 | +31.7% | $5.0M | 2025-Q4 |
| Nuveen, LLC | ADD | 74,667 | 111,028 | +48.7% | $883.8K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 21,947 | 40,629 | +85.1% | $323.4K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 12,249 | 26,322 | +114.9% | $209.5K | 2025-Q4 |
| DEUTSCHE BANK AG\ | TRIM | 32,767 | 24,366 | -25.6% | $194.0K | 2025-Q4 |
| MetLife Investment Management, LLC | ADD | 10,067 | 19,085 | +89.6% | $151.9K | 2025-Q4 |
| Invesco Ltd. | ADD | 14,335 | 18,628 | +29.9% | $148.3K | 2025-Q4 |
| Russell Investments Group, Ltd. | TRIM | 3,921 | 2,671 | -31.9% | $21.3K | 2025-Q4 |
| STRS OHIO | TRIM | 9,100 | 2,300 | -74.7% | $18.3K | 2025-Q4 |
| FMR LLC | DOUBLED | 97 | 1,804 | +1759.8% | $14.4K | 2025-Q4 |
| GROUP ONE TRADING LLC | DOUBLED | 387 | 1,389 | +258.9% | $11.1K | 2025-Q4 |
| PNC FINANCIAL SERVICES GROUP, INC. | NEAR_EXIT | 450 | 57 | -87.3% | $454.00 | 2025-Q4 |
| BlackRock, Inc. | ADD | 1,191,813 | 1,678,139 | +40.8% | $11.5M | 2025-Q3 |
| VANGUARD GROUP INC | TRIM | 1,535,054 | 664,575 | -56.7% | $4.6M | 2025-Q3 |
9 unique insiders with 9 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Kuntz Richard | Director | AWARD | 40,412 | — | — |
| Jun 1, 2026 | Giuffre Randall Michael | Director | AWARD | 40,412 | — | — |
| Jun 1, 2026 | O'Connor Daniel J. | Director | AWARD | 40,412 | — | — |
| Jun 1, 2026 | Semba Charles Pauling | Director | AWARD | 40,412 | — | — |
| Jun 1, 2026 | Kellen Scott | CFO & Secretary | AWARD | 162,000 | — | — |
| Jun 1, 2026 | Krop Julie | Chief Medical Officer | AWARD | 67,500 | — | — |
| Jun 1, 2026 | Pauls Dietrich John | President & CEO | AWARD | 380,000 | — | — |
| Jun 1, 2026 | Lewis Tanya | Director | AWARD | 40,412 | — | — |
| Jun 1, 2026 | Parsons James T. | Director | AWARD | 51,189 | — | — |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 4.0/10.
NEUTRAL
INST-CLUSTER
3/10
Three mega-passive institutional investors (BlackRock, State Street, Morgan Stanley) collectively ad
Jun 11, 2026
BEARISH
8-K
6/10
DiaMedica reported Q1 2026 EPS of -$0.19, missing consensus of -$0.17 by 11.8%. Net loss widened to
May 6, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Nov 2025): 91% buy across 11 analysts — 2 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$15.50 mean target (Nov 2025)
$11.00 Low
$25.00 High
| Metric | Value |
|---|---|
| Current Price | $5.65 |
| Target Low | $11.00 |
| Target Mean | $15.50 |
| Target Median | $13.00 |
| Target High | $25.00 |
| # Analysts | 4 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.20 | $-0.21 | $-0.19 | -11.1% | -5.3% | 2↑ 0↓ | $0.0B | 0.0% | 4 |
| Next Q 2026-09-30 |
$-0.21 | $-0.24 | $-0.19 | -25.0% | -3.7% | 2↑ 1↓ | $0.0B | 0.0% | 4 |
| Current FY 2026-12-31 |
$-0.83 | $-0.90 | $-0.76 | -18.6% | -3.4% | 2↑ 2↓ | $0.0B | 0.0% | 4 |
| Next FY 2027-12-31 |
$-0.88 | $-1.05 | $-0.58 | -6.0% | -5.3% | 1↑ 2↓ | $0.0B | 0.0% | 5 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.200 | |
| 7d ago | $-0.190 | -0.010 |
| 30d ago | $-0.190 | -0.010 |
| 60d ago | $-0.207 | +0.007 |
| 90d ago | $-0.207 | +0.007 |
7 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 5 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 14, 2025 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Aug 15, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jul 18, 2025 | Craig-Hallum | MAINTAIN | Buy | Buy |
| Jul 18, 2025 | Lake Street | MAINTAIN | Buy | Buy |
| Jul 18, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| May 29, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Mar 19, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Oct 10, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Oct 7, 2024 | HC Wainwright & Co. | INITIATE | — | Buy |
| Aug 16, 2024 | Oppenheimer | REITERATE | Outperform | Outperform |
| Mar 21, 2024 | Craig-Hallum | MAINTAIN | Buy | Buy |
| Mar 21, 2024 | Oppenheimer | REITERATE | Outperform | Outperform |
| Jun 22, 2023 | Oppenheimer | UPGRADE | Perform | Outperform |
| Jul 7, 2022 | Lake Street | MAINTAIN | — | Buy |
| Jul 7, 2022 | Craig-Hallum | MAINTAIN | — | Buy |
| Jul 7, 2022 | Oppenheimer | DOWNGRADE | Outperform | Perform |
| Jun 30, 2021 | Roth Capital | MAINTAIN | — | Buy |
| Apr 8, 2021 | Oppenheimer | INITIATE | — | Outperform |
| Feb 17, 2021 | Roth Capital | INITIATE | — | Buy |
| Jul 8, 2020 | Maxim Group | INITIATE | — | Buy |
| May 15, 2020 | Craig-Hallum | MAINTAIN | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| May 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Apr 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Mar 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Feb 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Jan 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 6, 2026
earnings_calendar
DMAC Q1 2026 Earnings After Market Close — 2026-05-06
Mar 31, 2026
earnings_calendar
DMAC Q4 2025 Earnings After Market Close — 2026-03-31
Mar 30, 2026
earnings_calendar
DMAC Q4 2025 Earnings After Market Close — 2026-03-30